Leading UK wealth management firm, Brewin Dolphin, is leading the fight against blood cancer with a headline sponsorship for premier cycling event London 2 Paris: Inspiring The Revolution. The 500km cycle ride from Greenwich to the French capital from May 19th – 23rd 2016 will involve up to 300 cyclists, led by former England and Crystal Palace footballer and blood cancer survivor Geoff Thomas.
Over 40 cyclists will be joining ‘Team Revolution’ for the four-day ride to Paris with each rider raising funds for the charity. Cure Leukaemia’s relationship with pharmaceutical companies means the funds raised will be worth ten times more in potentially life-saving treatments for blood cancer patients.
Co-Head of Private Clients at Brewin Dolphin, Stephen Jones, will be a member of the peloton and is no stranger to cycling huge distances after he completed all 21 stages of the Tour de France, one day ahead of the professionals in July last year to raise funds for Cure Leukaemia.
Stephen Jones said:
“Last year I met Cure Leukaemia’s co-founder Professor Charlie Craddock CBE and patients who are directly benefitting from funds raised by the charity. The work Cure Leukaemia supports at the Centre for Clinical Haematology (CCH) at the Queen Elizabeth Hospital, Birmingham has a global impact on the fight against blood cancer.
Brewin Dolphin are proud members of the Birmingham community and are honoured to support Cure Leukaemia because we know the funds will not only directly benefit patients, but also continue working towards finding a cure for all forms of blood cancer.
We have riders from our offices throughout the country taking part and I’m sure it will be a fantastic experience for a very serious and important cause.”
Cure Leukaemia Chief Executive James McLaughlin said:
“To have such a well respected and influential company such as Brewin Dolphin fronting our London 2 Paris ride will not only provide vital treatments for patients battling this dreadful disease, but also raise the profile of the charity throughout the country.
As highlighted in the national media recently, Professor Craddock and his clinical team are administering world first clinical trials at the CCH in Birmingham and across the Midlands that are only possible with Cure Leukaemia’s funding. Brewin Dolphin’s support will help save lives and continue progress towards a cure for all blood cancers.”
To sponsor the Brewin Dolphin team:
Cure Leukaemia's £1m Centre Appeal 2017